Your browser doesn't support javascript.
loading
Trace amine-associated receptor 1 activation silences GSK3ß signaling of TAAR1 and D2R heteromers.
Harmeier, Anja; Obermueller, Stefan; Meyer, Claas A; Revel, Florent G; Buchy, Daniele; Chaboz, Sylvie; Dernick, Gregor; Wettstein, Joseph G; Iglesias, Antonio; Rolink, Antonius; Bettler, Bernhard; Hoener, Marius C.
Afiliación
  • Harmeier A; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Obermueller S; Therapeutic Modalities, Discovery Technologies, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Meyer CA; Therapeutic Modalities, Discovery Technologies, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Revel FG; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Buchy D; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Chaboz S; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Dernick G; Therapeutic Modalities, Discovery Technologies, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Wettstein JG; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Iglesias A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Rolink A; Department of Biomedicine, Developmental and Molecular Immunology, Pharmazentrum, University of Basel, CH-4058 Basel, Switzerland.
  • Bettler B; Department of Biomedicine, Institute of Physiology, Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland.
  • Hoener MC; Neuroscience, Ophthalmology and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland. Electronic address: marius.hoener@roche.com.
Eur Neuropsychopharmacol ; 25(11): 2049-61, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26372541
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Receptores de Dopamina D2 / Arrestinas / Glucógeno Sintasa Quinasa 3 / Receptores Acoplados a Proteínas G Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Receptores de Dopamina D2 / Arrestinas / Glucógeno Sintasa Quinasa 3 / Receptores Acoplados a Proteínas G Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Suiza